Skip to main content

The Canadian National Breast Screening Studies are compromised and their results are unreliable. They should not factor into decisions about breast cancer screening

Breast Cancer Research and Treatment volume 165, pages 9–15 (2017)Cite this article

A Letter to the Editor to this article was published on 30 August 2017

Abstract

The Canadian National Breast Screening Studies were compromised by an unblinded allocation process and poor quality mammography. Contrary to the requirement that allocation in a randomized controlled trial (RCT) be blinded to avoid any possible intentional or unintentional subversion of a random allocation, all women in the CNBSS trials underwent a clinical breast examination prior to assignment to the study arm or the usual care arm. Women with abnormal clinical breast examinations were identified, and this information was available to the coordinators who then assigned the women on open lists. It was, therefore, possible to assign women to whichever arm the coordinator chose. Although subversion was likely unintended, a significant number of women with four or more positive axillary lymph nodes were assigned to the screening arm of CNBSS1. This explains why there were more breast cancer deaths among the screened women in the first ten years of the trial and why the 5 year survival of the control women was better than 90% when the background survival in Canada at the time was only 75%. The trials were further compromised by the poor quality of the mammography which was confirmed by a review conducted by the trials’ organizers. These fundamental problems compromise the CNBSS and make their results, which are major outliers in the RCT’s of breast cancer screening, unreliable. Consequently, they should not be used to establish guidelines for breast cancer screening.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Duffy SW, Tabar L, Smith RA (2002) The mammographic screening trials: commentary on the recent work by Olsen and Gotzsche. CA A Cancer J Clin 52:68–71

    Article  Google Scholar 

  2. Hendrick RE, Smith RA, Rutledge JH, Smart CR (1997) Benefit of screening mammography in women ages 40-49: a new meta- analysis of randomized controlled trials. J Natl Cancer Inst Monogr 22:87–92

    Article  Google Scholar 

  3. Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380(9855):1778–1786

    Article  Google Scholar 

  4. Tabar L, Vitak B, Tony HH, Yen MF, Duffy SW, Smith RA (2001) Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 91:1724–1731

    CAS  Article  PubMed  Google Scholar 

  5. Kopans DB (2002) Beyond randomized, controlled trials: organized mammographic screening substantially reduces breast cancer mortality. Cancer 94:580–581

    Article  PubMed  Google Scholar 

  6. Duffy SW, Tabar L, Chen H, Holmqvist M, Yen M, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A, Tholin M, Wiege M, Akerlund A, Wu H, Tung T, Chiu Y, Chiu C, Huang C, Smith RA, Rosén M, Stenbeck M, Holmberg L (2002) The Impact of Organized Mammography Service Screening on Breast Carcinoma Mortality in Seven Swedish Counties. Cancer 95:458–469

    Article  PubMed  Google Scholar 

  7. Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ, National Evaluation Team for Breast Cancer Screening (2003) Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 361:411–417

    Article  Google Scholar 

  8. Swedish Organised Service Screening Evaluation Group (2006) Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomark Prev 15:45–51

    Article  Google Scholar 

  9. Coldman A, Phillips N, Warren L, Kan L (2007) Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer 120(5):1076–1080

    CAS  Article  PubMed  Google Scholar 

  10. Jonsson H, Bordás P, Wallin H, Nyström L, Lenner P (2007) Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update. J Med Screen 14(2):87–93

    Article  Google Scholar 

  11. Paap E, Holland R, den Heeten GJ et al (2010) A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study. Cancer Causes Control 21:1569–1573

    Article  PubMed  Google Scholar 

  12. Otto SJ, Fracheboud J, Verbeek ALM, Boer R, Reijerink-Verheij JCIY, Otten JDM, Broeders MJM, de Koning HJ, National Evaluation Team for Breast Cancer Screening (2011) Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomark Prev. doi:10.1158/1055-9965.EPI-11-0476

    Google Scholar 

  13. van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL (2011) Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 104(6):910–914

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mandelblatt JS, Cronin KA, Bailey S et.al (2009) Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 151:738–747. http://cisnet.cancer.gov. Accessed 16 April 2011

  15. Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, Viták B, Zackrisson S, Nyström L, Jonsson H (2011) Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 117(4):714–722

    Article  PubMed  Google Scholar 

  16. Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E; EUROSCREEN Working Group (2012) The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 19(Suppl 1):14–25

    Article  PubMed  Google Scholar 

  17. Hofvind S, Ursin G, Tretli S, Sebuødegård S, Møller B (2013) Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. Cancer 119(17):3106–3112

    Article  PubMed  Google Scholar 

  18. Sigurdsson K, Olafsdóttir EJ (2013) Population-based service mammography screening: the Icelandic experience. Breast Cancer (Dove Med Press) 9(5):17–25

    Google Scholar 

  19. Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, Zhang B, Payne J, Doyle G, Ahmad R (2014) Pan-canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst. doi:10.1093/jnci/dju261

    PubMed  Google Scholar 

  20. Webb ML, Cady B, Michaelson JS, Bush DM, Calvillo KZ, Kopans DB, Smith BL (2014) A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer 120(18):2839–2846

    Article  PubMed  Google Scholar 

  21. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ, Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network (2009) Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 151(10):738–747

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kopans DB (2009) US Preventive Services Task Force (USPSTF) Guidelines are not supported by science: the scientific support for mammography screening. Radiol Clin North Am 48(5):843–857

    Article  Google Scholar 

  23. Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E, EUROSCREEN Working Group (2012) Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 19(Suppl 1):42–56

    Article  PubMed  Google Scholar 

  24. Alexander FE, Anderson TJ, Forrest APM, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A (2000) 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 353:1903–1908

    Article  Google Scholar 

  25. Miller AB, Howe GR, Wall C (1981) The National Study of Breast Cancer Screening protocol for a Canadian randomized controlled trial of screening for breast cancer in women. Clin Investig Med 4(3–4):227–258

    CAS  Google Scholar 

  26. Miller AB, Baines CJ, Turnbull C (1991) The role of the nurse-examiner in the National Breast Screening Study. Can J Public Health 82(3):162–167

    CAS  PubMed  Google Scholar 

  27. American Roentgen Ray Society Meeting “Breast Imaging The Great Debate” (2015) The Fairmont Royal York 100 Front Street West. Canada, Toronto

    Google Scholar 

  28. Merz B (1992) Author of Canadian Breast Cancer Study retracts warnings. J Natl Cancer Inst 84(11):832–834

    CAS  Article  PubMed  Google Scholar 

  29. Personal Communication with permission from Wende Logan-Young, M.D. 2/2107 – Minutes of the “6th Meeting Policy Advisory Group National Office National Cancer Institute of Canada, Toronto, Canada 9 May 1983.”

  30. Personal Communication with permission Stephen Feig, M.D. 2/16/2017

  31. Personal Communication from Laszlo Tabar, M.D. with permission 2/2017

  32. Baines CJ, Miller AB, Kopans DB, Moskowitz M, Sanders DE, Sickles EA, To T, Wall C (1990) Canadian National Breast Screening Study: assessment of technical quality by external review. AJR Am J Roentgenol 155(4):743–747

    CAS  Article  PubMed  Google Scholar 

  33. Kopans DB (1990) The Canadian screening program: a different perspective. AJR 155:748–749

    Article  Google Scholar 

  34. Yaffe MJ (1993) Correction: Canada study. Lett Edit JNCI 85:94

    Google Scholar 

  35. Tony Miller on Canadian Television. http://tvo.org/video/201382/are-mammograms-working. Accessed 4 Dec 2015

  36. Boyd NF, Jong RA, Yaffe MJ, Tritchler D, Lockwood G, Zylak CJ (1993) A critical appraisal of the Canadian National Breast Cancer Screening Study. Radiology 189:661–663

    CAS  Article  PubMed  Google Scholar 

  37. Burhenne LJ, Burhenne HJ (1993) The Canadian National Breast Screening Study: a Canadian critique. AJR Am J Roentgenol 161(4):761–763

    CAS  Article  PubMed  Google Scholar 

  38. Tabár L, Yen AM, Wu WY, Chen SL, Chiu SY, Fann JC, Ku MM, Smith RA, Duffy SW, Chen TH (2015) Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast J 21(1):13–20

    Article  PubMed  Google Scholar 

  39. Kopans DB, Feig SA (1993) The Canadian National Breast Screening Study: a critical review. AJR 161:755–760

    CAS  Article  PubMed  Google Scholar 

  40. Tarone RE (1995) The excess of patients with advanced breast cancers in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 75:997–1003

    CAS  Article  PubMed  Google Scholar 

  41. Bailar JC, MacMahon B (1997) Randomization in the Canadian National Breast Screening Study: a review for evidence of subversion. Can Med Assoc J 156:193–199

    Google Scholar 

  42. Kopans DB (1997) NBSS: opportunity to compromise the process. Lett Edit Can Med Assoc J 157:247

    CAS  Google Scholar 

  43. http://www.huffingtonpost.com/h-gilbert-welch/ockhams-razor-revisited-a_b_6669886.html. Accessed 3 April 2017

  44. Kopans DB (1994) Screening for breast cancer and mortality reduction among women 40-49 years of age. Cancer 74(1 Suppl):311–322

    CAS  Article  PubMed  Google Scholar 

  45. Miller AB, Baines CJ, To T, Wall C (1992) Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 147(10):1459–1476

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Kopans DB (2004) Get the facts straight. J Clin Oncol 22(23):4859

    Article  PubMed  Google Scholar 

  47. Stacey-Clear A, McCarthy KA, Hall DA, Pile-Spellman E, White G, Hulka C, Whitman GJ, Mahoney E, Kopans DB (1992) Breast cancer survival among women under age 50: is mammography detrimental? Lancet 340:991–994

    CAS  Article  PubMed  Google Scholar 

  48. Baines CJ (1994) A different view on what is known about breast screening and the Canadian National Breast Screening Study. Cancer 74(4):1207–1211

    CAS  Article  PubMed  Google Scholar 

  49. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 11(348):g366. doi:10.1136/bmj.g366

    Article  Google Scholar 

  50. Page 1 of 3 Feb 21, 2014 08:47:19PM MSTDon’t slam Canada for mammogram study By H. Gilbert Welch. http://www.cnn.com/2014/02/19/opinion/welch-mammograms-canada/index.html?iref=allsearchCNN.COM. Accessed 12 April 2016

  51. Michaelson J, Satija S, Kopans D, Moore R, Sliverstein M, Comegno A, Hughes K, Taghian A, Powell S, Smith B (2003) Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. Cancer 98:2114–2124

    Article  Google Scholar 

  52. Page 1 of 3 Feb 21, 2014 08:47:19PM MSTDon’t slam Canada for mammogram study By H. Gilbert Welch. http://www.cnn.com/2014/02/19/opinion/welch-mammograms-canada/index.html?iref=allsearchCNN.COM. Accessed 12 April 2016

  53. Bock K, Borisch B, Cawson J, Damtjernhaug B, de Wolf C, Dean P, den Heeten A, Doyle G, Fox R, Frigerio A, Gilbert F, Hecht G, Heindel W, Heywang-Köbrunner SH, Holland R, Jones F, Lernevall A, Madai S, Mairs A, Muller J, Nisbet P, O’Doherty A, Patnick J, Perry N, Regitz-Jedermann L, Rickard M, Rodrigues V, Del Turco MR, Scharpantgen A, Schwartz W, Seradour B, Skaane P, Tabar L, Tornberg S, Ursin G, Van Limbergen E, Vandenbroucke A, Warren LJ, Warwick L, Yaffe M, Zappa M (2011) Effect of population-based screening on breast cancer mortality. Lancet 378(9805):1775–1776. doi:10.1016/S0140-6736(11)61766-2

    Article  PubMed  Google Scholar 

  54. Gøtzsche PC, Jørgensen KJ (2013) Screening for breast cancer with mammography. Cochrane Database Syst Rev. doi:10.1002/14651858.CD001877

    Google Scholar 

Download references

Author information

Affiliations

  1. Breast Imaging Division, Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA

    Daniel B. Kopans

  2. 20 Manitoba Road, Waban, MA, 02468, USA

    Daniel B. Kopans

Authors
  1. Daniel B. Kopans
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel B. Kopans.

Ethics declarations

Conflicts of interest

The authors declare that they have no competing interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kopans, D.B. The Canadian National Breast Screening Studies are compromised and their results are unreliable. They should not factor into decisions about breast cancer screening. Breast Cancer Res Treat 165, 9–15 (2017). https://doi.org/10.1007/s10549-017-4302-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-017-4302-9

Keywords

  • Breast
  • Breast cancer
  • Screening
  • Randomized trials
  • Mammography